4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
BioPharma Credit Ord (BPCR) operates in the Investment Trusts industry. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, BPCR reported $132M in revenue and $130M in net income.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $132M | $124M | $110M | $184M | — |
| Net Income | $130M | $122M | $108M | $182M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | ($110M) | ($175M) | ($90M) | ($156M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.2B | $1.2B | $1.4B | $1.4B | — |
| Total Liabilities | $18M | $18M | $16M | $27M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BPCR viewer.
About TickerBase · Data methodology & sources · Privacy · Terms